2022 Annual Meeting | Panel - Thinking about Practice Models in my Future Career

Date Thursday 04/07/22

Time 02:30 PM - 03:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Learner Engagement Center (The Neuro Trainee and Educator Junction)

Director(s) Daniel J. Ackerman, MD, FAAN

Topic(s) General Neurology

Learning Objectives At the end of this presenation learners will be ready for the change from competing fiercely for a spot to being recruited; be able to differentiate between recent practice models in neurology; and be more prepared to decide which practice model makes sense in the setting of their personal and professional goals.

CME Available No CME available

Recommended Audience Fellow, Resident, Medical Student

Teaching Styles Panel Discussion

Program Materials Program Evaluations

Event Timeline
02:30 PM - 03:30 PM PDT	Speaker	Panel - Thinking about Practice Models in my Future Career Karen D. Orjuela, MD, FAAN, Jose H. Posas, MD, FAAN, Daniel J. Ackerman, MD, FAAN

Faculty Disclosures
Daniel J. Ackerman, MD, FAAN	Dr. Ackerman has nothing to disclose.
Jose H. Posas, MD, FAAN	Dr. Posas has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Posas has a non-compensated relationship as a Advisor with Dane Health that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Lecturer with Concussion Corner Academy that is relevant to AAN interests or activities.
Karen D. Orjuela, MD, FAAN	The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation.